Company Filing History:
2 out of 993 
2 out of 107 
1 out of 3 Years Active: 2020-2023
Title: Shinya Murase: Innovator in Immune Checkpoint Inhibitors
Introduction
Shinya Murase is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target immune checkpoint inhibitors. With a total of 2 patents, his work is pivotal in advancing treatments for diseases associated with immune dysfunction.
Latest Patents
Murase's latest patents include a compound that has a PD-L1 expression-suppressing action. This invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, which exhibits an inhibitory effect on PD-L1 expression and reduces the production of IL-2. This medicament is useful for treating diseases linked to reduced immune function caused by the formation of PD-1/PD-L1 binding. Another notable patent is an indole alkaloid compound that has immune checkpoint inhibitory action. This invention offers a medicament useful for the treatment and/or prevention of cancer, serving as a vaccine adjuvant and an inhibitor of immune checkpoints.
Career Highlights
Throughout his career, Shinya Murase has worked with esteemed institutions such as Tohoku University and Fuso Pharmaceutical Industries, Ltd. His research and innovations have significantly impacted the pharmaceutical industry, particularly in cancer treatment and immune response modulation.
Collaborations
Murase has collaborated with notable colleagues, including Haruhisa Kikuchi and Yoshiteru Oshima. These partnerships have fostered advancements in research and development within the field of immunology.
Conclusion
Shinya Murase's contributions to the field of immune checkpoint inhibitors are noteworthy. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.